Identification of TgENT1 as the TgUUT1 Uracil/Uridine Transporter of Toxoplasma gondii
Pathogens · 02.03.2026 · 15 (3) · 266
DOI: 10.3390/pathogens15030266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 02.03.2026. Verfasst von Hamza A A Elati und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK. Hauptthemen laut MEDLINE: Toxoplasma, Uracil, Uridine, Protozoan Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome Investigator Award, Wellcome Discovery Award.
Abstract (Originalsprache)
The protozoan pathogen Toxoplasma gondii is responsible for toxoplasmosis, a disease that can be deadly in immunocompromised patients and the developing fetus during pregnancy. Current treatments are widely considered to be suboptimal. We have recently reported that 5-fluoropyrimidines have highly promising anti-toxoplasmosis effects and are internalized by the parasite by a high-affinity uracil/uridine transporter, TgUUT1. Here, we attempt to identify the gene encoding this transport protein. The only nucleoside or nucleobase family identified in the T. gondii genome was the Equilibrative Nucleoside Transporter (ENT) family, with four members. Of these, TgAT1 is known to be purine-specific, and deletion of the TgENT2 and TgENT3 genes, either separately or jointly, did not affect uridine transport or sensitivity to 5-fluoropyrimidines. In contrast, depletion of TgENT1, an essential gene, resulted in a significant reduction in the uptake of both uracil and uridine but not of the amino acid tryptophan. Moreover, expression of TgENT1 in a Leishmania mexicana cell line with low endogenous uracil uptake rates significantly increased uracil uptake for these cells. We conclude that it is highly probable that TgENT1 encodes the T. gondii uracil/uridine transporter. On the basis of our previous results, we infer that TgENT1 likely also mediates the uptake of 5-fluoropyrimidines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK.
- Centre for Parasitology, School of Infection & Immunity, Sir Graeme Davies Building, University of Glasgow, Glasgow G12 8TA, UK.
- Department of Pharmacology and Toxicology, Pharmacy College, University of Elmergib, Al Khums 40414, Libya.
ORCID-Profile: Hamza A A Elati, Mariana Ferreira Silva, Lilach Sheiner, Harry P de Koning
Förderung
- Wellcome Trust
- Wellcome Investigator Award
- Wellcome Discovery Award
- the government of Libya
Zitieren
APA
Elati, H. A. A., Ferreira Silva, M., Sheiner, L., & de Koning, H. P. (2026). Identification of TgENT1 as the TgUUT1 Uracil/Uridine Transporter of Toxoplasma gondii. Pathogens, 15(3), 266. https://doi.org/10.3390/pathogens15030266
Vancouver
Elati HAA, Ferreira Silva M, Sheiner L, de Koning HP. Identification of TgENT1 as the TgUUT1 Uracil/Uridine Transporter of Toxoplasma gondii. Pathogens. 2026;15(3):266. doi:10.3390/pathogens15030266
BibTeX
@article{Elati2026,
author = {Elati, Hamza A A and Ferreira Silva, Mariana and Sheiner, Lilach and de Koning, Harry P},
title = {Identification of TgENT1 as the TgUUT1 Uracil/Uridine Transporter of Toxoplasma gondii},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {3},
pages = {266},
doi = {10.3390/pathogens15030266}
}
EUVIMED